1	Impaired	_	JJ	_	_	4	NMOD	_	_
2	CK1	_	NN	_	_	4	NMOD	_	_
3	delta	_	NN	_	_	4	NMOD	_	_
4	activity	_	NN	_	_	5	VMOD	_	_
5	attenuates	_	VBZ	_	_	0	ROOT	_	_
6	SV40-induced	_	JJ	_	_	8	NMOD	_	_
7	cellular	_	JJ	_	_	8	NMOD	_	_
8	transformation	_	NN	_	_	5	VMOD	_	_
9	in	_	FW	_	_	8	COORD	_	_
10	vitro	_	FW	_	_	9	AMOD	_	_
11	and	_	CC	_	_	9	COORD	_	_
12	mouse	_	NN	_	_	14	NMOD	_	_
13	mammary	_	JJ	_	_	14	NMOD	_	_
14	carcinogenesis	_	NN	_	_	11	CONJ	_	_
15	in	_	FW	_	_	14	COORD	_	_
16	vivo	_	FW	_	_	15	AMOD	_	_
17	.	_	.	_	_	5	P	_	_
		
1	Simian	_	JJ	_	_	2	NMOD	_	_
2	virus	_	NN	_	_	7	VMOD	_	_
3	40	_	CD	_	_	2	NMOD	_	_
4	(	_	(	_	_	5	P	_	_
5	SV40	_	NN	_	_	2	PRN	_	_
6	)	_	)	_	_	5	P	_	_
7	is	_	VBZ	_	_	0	ROOT	_	_
8	a	_	DT	_	_	10	NMOD	_	_
9	powerful	_	JJ	_	_	10	NMOD	_	_
10	tool	_	NN	_	_	7	VMOD	_	_
11	to	_	TO	_	_	10	NMOD	_	_
12	study	_	VB	_	_	11	IM	_	_
13	cellular	_	JJ	_	_	14	NMOD	_	_
14	transformation	_	NN	_	_	12	VMOD	_	_
15	in	_	FW	_	_	14	NMOD	_	_
16	vitro	_	FW	_	_	15	AMOD	_	_
17	,	_	,	_	_	14	P	_	_
18	as	_	RB	_	_	14	COORD	_	_
19	well	_	RB	_	_	18	DEP	_	_
20	as	_	IN	_	_	18	DEP	_	_
21	tumor	_	NN	_	_	22	NMOD	_	_
22	development	_	NN	_	_	18	CONJ	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	progression	_	NN	_	_	23	CONJ	_	_
25	in	_	FW	_	_	12	VMOD	_	_
26	vivo	_	FW	_	_	25	AMOD	_	_
27	.	_	.	_	_	7	P	_	_
		
1	Various	_	JJ	_	_	3	NMOD	_	_
2	cellular	_	JJ	_	_	3	NMOD	_	_
3	kinases	_	NNS	_	_	13	VMOD	_	_
4	,	_	,	_	_	3	P	_	_
5	among	_	IN	_	_	3	NMOD	_	_
6	them	_	PRP	_	_	5	PMOD	_	_
7	members	_	NNS	_	_	6	APPO	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	CK1	_	NN	_	_	11	NMOD	_	_
11	family	_	NN	_	_	8	PMOD	_	_
12	,	_	,	_	_	3	P	_	_
13	play	_	VBP	_	_	0	ROOT	_	_
14	an	_	DT	_	_	16	NMOD	_	_
15	important	_	JJ	_	_	16	NMOD	_	_
16	role	_	NN	_	_	13	VMOD	_	_
17	in	_	IN	_	_	13	VMOD	_	_
18	modulating	_	VBG	_	_	17	PMOD	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	transforming	_	VBG	_	_	21	NMOD	_	_
21	activity	_	NN	_	_	18	VMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	SV40	_	NN	_	_	22	PMOD	_	_
24	,	_	,	_	_	13	P	_	_
25	including	_	VBG	_	_	13	VMOD	_	_
26	the	_	DT	_	_	28	NMOD	_	_
27	transforming	_	VBG	_	_	28	NMOD	_	_
28	activity	_	NN	_	_	25	VMOD	_	_
29	of	_	IN	_	_	28	NMOD	_	_
30	T-Ag	_	NN	_	_	29	PMOD	_	_
31	,	_	,	_	_	30	P	_	_
32	the	_	DT	_	_	35	NMOD	_	_
33	major	_	JJ	_	_	35	NMOD	_	_
34	transforming	_	NN	_	_	35	NMOD	_	_
35	protein	_	NN	_	_	30	APPO	_	_
36	of	_	IN	_	_	35	NMOD	_	_
37	SV40	_	NN	_	_	36	PMOD	_	_
38	,	_	,	_	_	30	P	_	_
39	itself	_	PRP	_	_	28	APPO	_	_
40	.	_	.	_	_	13	P	_	_
		
1	Here	_	RB	_	_	3	VMOD	_	_
2	we	_	PRP	_	_	3	VMOD	_	_
3	characterized	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	effects	_	NNS	_	_	3	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	mutant	_	JJ	_	_	9	NMOD	_	_
8	CK1delta	_	NN	_	_	9	NMOD	_	_
9	variants	_	NNS	_	_	6	PMOD	_	_
10	with	_	IN	_	_	9	NMOD	_	_
11	impaired	_	JJ	_	_	13	NMOD	_	_
12	kinase	_	NN	_	_	13	NMOD	_	_
13	activity	_	NN	_	_	10	PMOD	_	_
14	on	_	IN	_	_	5	NMOD	_	_
15	SV40-induced	_	JJ	_	_	17	NMOD	_	_
16	cell	_	NN	_	_	17	NMOD	_	_
17	transformation	_	NN	_	_	14	PMOD	_	_
18	in	_	IN	_	_	17	NMOD	_	_
19	vitro	_	FW	_	_	18	PMOD	_	_
20	,	_	,	_	_	14	P	_	_
21	and	_	CC	_	_	14	COORD	_	_
22	on	_	IN	_	_	21	CONJ	_	_
23	SV40-induced	_	JJ	_	_	25	NMOD	_	_
24	mammary	_	JJ	_	_	25	NMOD	_	_
25	carcinogenesis	_	NN	_	_	22	PMOD	_	_
26	in	_	FW	_	_	3	VMOD	_	_
27	vivo	_	FW	_	_	26	AMOD	_	_
28	in	_	IN	_	_	3	VMOD	_	_
29	a	_	DT	_	_	32	NMOD	_	_
30	transgenic/bi-transgenic	_	JJ	_	_	32	NMOD	_	_
31	mouse	_	NN	_	_	32	NMOD	_	_
32	model	_	NN	_	_	28	PMOD	_	_
33	.	_	.	_	_	3	P	_	_
		
1	CK1delta	_	NN	_	_	2	NMOD	_	_
2	mutants	_	NNS	_	_	3	VMOD	_	_
3	exhibited	_	VBD	_	_	0	ROOT	_	_
4	a	_	DT	_	_	7	NMOD	_	_
5	reduced	_	VBN	_	_	7	NMOD	_	_
6	kinase	_	NN	_	_	7	NMOD	_	_
7	activity	_	NN	_	_	3	VMOD	_	_
8	compared	_	VBN	_	_	3	VMOD	_	_
9	to	_	TO	_	_	8	PMOD	_	_
10	wtCK1delta	_	NN	_	_	9	PMOD	_	_
11	in	_	IN	_	_	3	VMOD	_	_
12	in	_	FW	_	_	13	AMOD	_	_
13	vitro	_	FW	_	_	15	NMOD	_	_
14	kinase	_	NN	_	_	15	NMOD	_	_
15	assays	_	NNS	_	_	11	PMOD	_	_
16	.	_	.	_	_	3	P	_	_
		
1	Molecular	_	JJ	_	_	3	NMOD	_	_
2	modeling	_	NN	_	_	3	NMOD	_	_
3	studies	_	NNS	_	_	4	VMOD	_	_
4	suggested	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	mutation	_	NN	_	_	7	NMOD	_	_
7	N172D	_	NN	_	_	16	VMOD	_	_
8	,	_	,	_	_	7	P	_	_
9	located	_	JJ	_	_	7	APPO	_	_
10	within	_	IN	_	_	9	AMOD	_	_
11	the	_	DT	_	_	14	NMOD	_	_
12	substrate	_	NN	_	_	14	NMOD	_	_
13	binding	_	NN	_	_	14	NMOD	_	_
14	region	_	NN	_	_	10	PMOD	_	_
15	,	_	,	_	_	7	P	_	_
16	is	_	VBZ	_	_	5	SUB	_	_
17	mainly	_	RB	_	_	18	AMOD	_	_
18	responsible	_	JJ	_	_	16	VMOD	_	_
19	for	_	IN	_	_	18	AMOD	_	_
20	impaired	_	JJ	_	_	22	NMOD	_	_
21	mutCK1delta	_	NN	_	_	22	NMOD	_	_
22	activity	_	NN	_	_	19	PMOD	_	_
23	.	_	.	_	_	4	P	_	_
		
1	When	_	WRB	_	_	3	VMOD	_	_
2	stably	_	RB	_	_	3	VMOD	_	_
3	over-expressed	_	VBN	_	_	12	VMOD	_	_
4	in	_	IN	_	_	3	VMOD	_	_
5	maximal	_	JJ	_	_	8	NMOD	_	_
6	transformed	_	JJ	_	_	8	NMOD	_	_
7	SV-52	_	NN	_	_	8	NMOD	_	_
8	cells	_	NNS	_	_	4	PMOD	_	_
9	,	_	,	_	_	12	P	_	_
10	CK1delta	_	NN	_	_	11	NMOD	_	_
11	mutants	_	NNS	_	_	12	VMOD	_	_
12	induced	_	VBD	_	_	0	ROOT	_	_
13	reversion	_	NN	_	_	12	VMOD	_	_
14	to	_	TO	_	_	13	NMOD	_	_
15	a	_	DT	_	_	18	NMOD	_	_
16	minimal	_	JJ	_	_	18	NMOD	_	_
17	transformed	_	JJ	_	_	18	NMOD	_	_
18	phenotype	_	NN	_	_	14	PMOD	_	_
19	by	_	IN	_	_	12	VMOD	_	_
20	dominant-negative	_	JJ	_	_	21	NMOD	_	_
21	interference	_	NN	_	_	19	PMOD	_	_
22	with	_	IN	_	_	21	NMOD	_	_
23	endogenous	_	JJ	_	_	24	NMOD	_	_
24	wtCK1delta	_	NN	_	_	22	PMOD	_	_
25	.	_	.	_	_	12	P	_	_
		
1	To	_	TO	_	_	0	ROOT	_	_
2	characterize	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	effects	_	NNS	_	_	2	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	CK1delta	_	NN	_	_	5	PMOD	_	_
7	on	_	IN	_	_	4	NMOD	_	_
8	SV40-induced	_	JJ	_	_	10	NMOD	_	_
9	mammary	_	JJ	_	_	10	NMOD	_	_
10	carcinogenesis	_	NN	_	_	7	PMOD	_	_
11	,	_	,	_	_	1	P	_	_
12	we	_	PRP	_	_	13	VMOD	_	_
13	generated	_	VBD	_	_	1	COORD	_	_
14	transgenic	_	JJ	_	_	15	NMOD	_	_
15	mice	_	NNS	_	_	13	VMOD	_	_
16	expressing	_	VBG	_	_	15	APPO	_	_
17	mutant	_	JJ	_	_	18	NMOD	_	_
18	CK1delta	_	NN	_	_	16	VMOD	_	_
19	under	_	IN	_	_	16	VMOD	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	control	_	NN	_	_	19	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	the	_	DT	_	_	31	NMOD	_	_
24	whey	_	NN	_	_	31	NMOD	_	_
25	acidic	_	JJ	_	_	31	NMOD	_	_
26	protein	_	NN	_	_	31	NMOD	_	_
27	(	_	(	_	_	31	P	_	_
28	WAP	_	NN	_	_	31	NMOD	_	_
29	)	_	)	_	_	31	P	_	_
30	gene	_	NN	_	_	31	NMOD	_	_
31	promoter	_	NN	_	_	22	PMOD	_	_
32	,	_	,	_	_	13	P	_	_
33	and	_	CC	_	_	13	COORD	_	_
34	crossed	_	VBD	_	_	33	CONJ	_	_
35	them	_	PRP	_	_	34	VMOD	_	_
36	with	_	IN	_	_	34	VMOD	_	_
37	SV40	_	NN	_	_	43	NMOD	_	_
38	transgenic	_	JJ	_	_	43	NMOD	_	_
39	WAP-T-antigen	_	NN	_	_	43	NMOD	_	_
40	(	_	(	_	_	43	P	_	_
41	WAP-T	_	JJ	_	_	43	NMOD	_	_
42	)	_	)	_	_	43	P	_	_
43	mice	_	NNS	_	_	36	PMOD	_	_
44	.	_	.	_	_	1	P	_	_
		
1	Both	_	CC	_	_	3	DEP	_	_
2	WAP-T	_	JJ	_	_	3	NMOD	_	_
3	mice	_	NNS	_	_	10	VMOD	_	_
4	as	_	RB	_	_	3	COORD	_	_
5	well	_	RB	_	_	4	DEP	_	_
6	as	_	IN	_	_	4	DEP	_	_
7	WAP-mutCK1delta/WAP-T	_	JJ	_	_	9	NMOD	_	_
8	bi-transgenic	_	JJ	_	_	9	NMOD	_	_
9	mice	_	NNS	_	_	4	CONJ	_	_
10	developed	_	VBD	_	_	0	ROOT	_	_
11	breast	_	NN	_	_	12	NMOD	_	_
12	cancer	_	NN	_	_	10	VMOD	_	_
13	.	_	.	_	_	10	P	_	_
		
1	However	_	RB	_	_	0	ROOT	_	_
2	,	_	,	_	_	1	P	_	_
3	tumor	_	NN	_	_	4	NMOD	_	_
4	incidence	_	NN	_	_	5	VMOD	_	_
5	was	_	VBD	_	_	1	COORD	_	_
6	lower	_	JJR	_	_	5	VMOD	_	_
7	and	_	CC	_	_	5	COORD	_	_
8	life	_	NN	_	_	9	NMOD	_	_
9	span	_	NN	_	_	10	VMOD	_	_
10	was	_	VBD	_	_	7	CONJ	_	_
11	significantly	_	RB	_	_	12	AMOD	_	_
12	longer	_	JJR	_	_	10	VMOD	_	_
13	in	_	IN	_	_	10	VMOD	_	_
14	WAP-mutCK1delta/WAP-T	_	JJ	_	_	16	NMOD	_	_
15	bi-transgenic	_	JJ	_	_	16	NMOD	_	_
16	animals	_	NNS	_	_	13	PMOD	_	_
17	.	_	.	_	_	1	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	reduced	_	VBN	_	_	4	NMOD	_	_
3	CK1delta	_	NN	_	_	4	NMOD	_	_
4	activity	_	NN	_	_	5	VMOD	_	_
5	did	_	VBD	_	_	0	ROOT	_	_
6	not	_	RB	_	_	5	VMOD	_	_
7	affect	_	VB	_	_	5	VC	_	_
8	early	_	JJ	_	_	10	NMOD	_	_
9	lesion	_	NN	_	_	10	NMOD	_	_
10	formation	_	NN	_	_	7	VMOD	_	_
11	during	_	IN	_	_	7	VMOD	_	_
12	tumorigenesis	_	NN	_	_	11	PMOD	_	_
13	,	_	,	_	_	7	P	_	_
14	suggesting	_	VBG	_	_	7	VMOD	_	_
15	that	_	IN	_	_	14	VMOD	_	_
16	impaired	_	JJ	_	_	18	NMOD	_	_
17	CK1delta	_	NN	_	_	18	NMOD	_	_
18	activity	_	NN	_	_	19	VMOD	_	_
19	reduces	_	VBZ	_	_	15	SUB	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	probability	_	NN	_	_	19	VMOD	_	_
22	for	_	IN	_	_	21	NMOD	_	_
23	outgrowth	_	NN	_	_	22	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	in	_	FW	_	_	26	AMOD	_	_
26	situ	_	FW	_	_	27	NMOD	_	_
27	carcinomas	_	NNS	_	_	24	PMOD	_	_
28	to	_	TO	_	_	23	NMOD	_	_
29	invasive	_	JJ	_	_	30	NMOD	_	_
30	carcinomas	_	NNS	_	_	28	PMOD	_	_
31	.	_	.	_	_	5	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	different	_	JJ	_	_	4	NMOD	_	_
3	tumorigenic	_	JJ	_	_	4	NMOD	_	_
4	potential	_	NN	_	_	12	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	SV40	_	NN	_	_	5	PMOD	_	_
7	in	_	IN	_	_	4	NMOD	_	_
8	WAP-T	_	JJ	_	_	11	NMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	WAP-mutCK1delta/WAP-T	_	JJ	_	_	9	CONJ	_	_
11	tumors	_	NNS	_	_	7	PMOD	_	_
12	was	_	VBD	_	_	0	ROOT	_	_
13	also	_	RB	_	_	12	VMOD	_	_
14	reflected	_	VBN	_	_	12	VC	_	_
15	by	_	IN	_	_	14	VMOD	_	_
16	a	_	DT	_	_	19	NMOD	_	_
17	significantly	_	RB	_	_	18	AMOD	_	_
18	different	_	JJ	_	_	19	NMOD	_	_
19	expression	_	NN	_	_	15	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	various	_	JJ	_	_	22	NMOD	_	_
22	genes	_	NNS	_	_	20	PMOD	_	_
23	known	_	VBN	_	_	22	APPO	_	_
24	to	_	TO	_	_	23	VMOD	_	_
25	be	_	VB	_	_	24	IM	_	_
26	involved	_	VBN	_	_	25	VC	_	_
27	in	_	IN	_	_	26	VMOD	_	_
28	tumor	_	NN	_	_	29	NMOD	_	_
29	progression	_	NN	_	_	27	PMOD	_	_
30	,	_	,	_	_	26	P	_	_
31	specifically	_	RB	_	_	26	VMOD	_	_
32	of	_	IN	_	_	31	AMOD	_	_
33	those	_	DT	_	_	32	PMOD	_	_
34	involved	_	VBN	_	_	33	APPO	_	_
35	in	_	IN	_	_	34	VMOD	_	_
36	wnt-signaling	_	NN	_	_	35	PMOD	_	_
37	and	_	CC	_	_	36	COORD	_	_
38	DNA	_	NN	_	_	39	NMOD	_	_
39	repair	_	NN	_	_	37	CONJ	_	_
40	.	_	.	_	_	12	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	data	_	NNS	_	_	3	VMOD	_	_
3	show	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	inactivating	_	VBG	_	_	6	NMOD	_	_
6	mutations	_	NNS	_	_	9	VMOD	_	_
7	in	_	IN	_	_	6	NMOD	_	_
8	CK1delta	_	NN	_	_	7	PMOD	_	_
9	impair	_	VBP	_	_	4	SUB	_	_
10	SV40-induced	_	JJ	_	_	12	NMOD	_	_
11	cellular	_	JJ	_	_	12	NMOD	_	_
12	transformation	_	NN	_	_	9	VMOD	_	_
13	in	_	FW	_	_	9	VMOD	_	_
14	vitro	_	FW	_	_	13	AMOD	_	_
15	and	_	CC	_	_	9	COORD	_	_
16	mouse	_	NN	_	_	18	NMOD	_	_
17	mammary	_	JJ	_	_	18	NMOD	_	_
18	carcinogenesis	_	NN	_	_	15	CONJ	_	_
19	in	_	IN	_	_	18	VMOD	_	_
20	vivo	_	FW	_	_	19	PMOD	_	_
21	.	_	.	_	_	3	P	_	_
		
